Simris Group AB
556841-9187ActivePioneering next-generation ADC payloads using proprietary cyanobacterial science.
Biotechnology Companysimrisgroup.com
Overview
- 5–9
- Employees
- 150–199K SEK
- Revenue
- 2011
- Founded
Description
Simris is a biotechnology company dedicated to revolutionizing cancer treatment through its proprietary pipeline of next-generation ADC payloads. These payloads are born from world-class cyanobacterial science, proprietary conjugation methods, and collaborations with leading research institutions. T...
Tags
B2BPharmaceuticals
Keywords
ADC
Nanohumps Biosciences Oy